Comparison of an amplified enzyme-linked immunosorbent assay with procedures based on molecular biology for assessing human immunodeficiency virus type 1 viral load

Clinical and Diagnostic Laboratory Immunology

Volumn 5, Issue 4, 1998, Pages 513-518

  Goldschmidt, Pablo L ^a   Devillechabrolle, Andrée ^a   Ait Arkoub, Zaina ^a   Aubin, Jean Thierry ^a  

^a PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN ANTIBODY COMPLEX; ARTICLE; ASSAY; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DISEASE COURSE; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; MOLECULAR BIOLOGY; PATIENT MONITORING; PLASMA; PRIORITY JOURNAL; VIRUS LOAD;

EID: 0031858041     PISSN: 1071412X     EISSN: None     Source Type: Journal    
DOI: 10.1128/cdli.5.4.513-518.1998     Document Type: Article

References (51)

1. Aoki, S., R. Yarchoan, R. V. Thomas, J. M. Pluda, K. Marczyk, S. Broder, and H. Mitsuya. 1990. Quantitative analysis of HIV-1 proviral DNA in peripheral mononuclear cells from patients with AIDS or ARC: decrease of proviral DNA content following treatment with 2′,3′-deoxyinosine (ddI). AIDS Res. Hum. Rctroviruses 6:1331-1339.
2. Aubin, J. T., D. Boulay, A. Chapus, C. Bréchot, F. Laure, and H. Agut. 1995. Evaluation of a new non-isotopic sandwich hybridization fur the detection of HIV1-specific PCR products. Res. Virol. 146:75-79.
3. Bagnarelli, P., S. Menzo, A. Valenza, S. Paolucci, S. Petroni, G. Scalise, R. Sampaolesi, A. Manzin, P. E. Varaldo, and M. clementi. 1995. Quantitative molecular monitoring of human immunodeficiency virus type 1 activity during therapy with specific antiretroviral compounds. J. Clin. Microbiol. 33:16-23.
4. Barlow, K. L., J. H. C. Tosswil, J. V. Parry, and J. P. Clewley. 1997. Performance of the Amplicor human immunodeficiency virus type 1 PCR and analysis of specimens with false-negative results. J. Clin. Microbiol. 35:2846-2853.
5. Bates, D. L. 1987. Enzyme amplification in diagnostics. Trends Biotechnol. 5: 204-209.
6. Binley, J. M., P. J. Klasse, Y. Cao, I. Jones, M. Markowitz, D. D. Ho, and J. P. Moore. 1997. Differential regulation of the antibody responses to Gag and Env proteins of human immunodeficiency virus type 1. J. Virol. 71:2799-2809.
7. Bobrow, M. N., T. D. Harris, K. J. Shaughnessy, and G. J. Litt. 1989. Catalyzed reporter deposition, a novel method of signal amplification. Application to immunoassays. J. Immunol. Methods 125:279-285.
8. Bollinger, R. C., R. L. Kline, H. L. Franics, M. W. Moss, J. G. Bartlett, and T. C. Quinn. 1992. Acid dissociation increases the sensitivity of p24 antigen deteclion for the evaluation of antiviral therapy and disease progression in asymptomatic human immunodeficiency virus-infected persons. J. Infect. Dis. 165:913-916.
9. Böni, J., M. Opravil, Z. Tomasik, M. Rothen, L. Bisset, P. Grob, R. Lüthy, and J. Sehüpbach. 1997. Simple monitoring of antiretroviral therapy with a signal-amplification-boosted HIV-1 p24 antigen assay with heat-denatured plasma. AIDS 11:F47-F52.
10. Boom, R., C. J. A. Sol, M. M. M. Salimans, C. L. Jansen, P. M. E. Wertheimvan Dillen, and J. van der Noordaa. 1990. Rapid and simple method for purification of nucleic acids. J. Clin. Microbiol. 28:495-503.
11. Bruisten, S. M., P. H. Frissen, P. Van Swieten, P. R. Harrigan, I. Kinghorn, B. Larder, and H. Weigel, 1997. Prospective longitudinal analysis of viral load and surrogate markers in relation to clinical progression in HIV type 1-infected persons. AIDS Res. Hum. Retroviruses 13:327-335.
12. Brun-Vezinet, F., and J. Dormont. 1996. Méthodes et indications. Mesure de la charge virale dans lc suivi des patients atteints par le VIH, p. 13-47. In Hommarion (ed.). Médecine-sciences, Paris, France.
13. Caliendo, A. M. 1995. Laboratory methods for quantitating HIV RNA. AIDS Clin. Care 7:89-91.
14. Cao, Y., F. Valentine, S. Hojvat, et al. 1987. Detection of HIV antigen and specific antibodies to HIV core and envelope proteins in sera of patients with HIV infection. Blood 70:575-578.
15. Clark, S. J., M. S. Saag, W. D. Decker, S. Campbell-Hill, J. L. Robertson, P. J. Veldkamp, J. C. Kapper, B. H. Hahn, and G. M. Shaw. 1991. High titers of cytopathic virus in plasma of patients with symptomatic primary HIV-1 infection. N. Engl. J. Med. 324:954-960.
16. Coombs, R. W., D. R. Henrard, W. F. Mehaffey, J. Gibson, E. Eggert, T. C. Quinn, and J. Phillips. 1993. Cell-free plasma human immunodeficiency type 1 titer assessed by culture and immunocapture-reverse transcription-polymerase chain reaction. J. Clin. Microbiol. 31:1980-1986.
17. Caste, J., B. Montes, J. Reynes, M. Peeters, C. Segarra, J. P. Vendrell, E. Delaporte, and M. Segondy. 1996. Comparative evaluation of three assays for the quantitation of human immunodeficiency virus type-1 RNA in plasma. J. Med. Virol. 50:293-302.
18. Defer, C., H. Agut, A. Garbarg-Chenon, M. Moncany, F. Morinet, F. Vignon, M. Mariotti, and J. J. Lefrère. 1992. Multicentre quality control of polymerase chain reaction for detection of HIV DNA. AIDS 6:659-663.
19. Delamare, C., M. Burgaud, M. J. Mayaux, S. Blanche, A. Doussin, S. Ivanoff, M. L. Chaix, C. Khan, and C. Rouzioux. 1997. HIV-1 RNA detection in plasma for the diagnosis of infection in neonates. The French Pediatric HIV Infection Study Group. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 15:121-125.
20. Dewar, R. L., et al. 1994. Application of branched DNA signal amplification to monitor human immunodeficiency virus type 1 burden in human plasma. J. Infect. Dis. 170:1172-1179.
21. Ferre, F., A. Marchese, P. C. Duffy, D. E. Lewis, M. R. Wallace, H. J. Beecham, K. G. Burnett, F. C. Jensen, and D. J. Carlo. 1992. Quantitation of HIV viral burden by PCR in HIV seropositive Navy personnel representing Walter Reed stages 1 to 6. AIDS Res. Hum. Retroviruses 8:269-275.
22. Gobbers, E., K. Fransen, T. Oosterlaken, W. Janssens, L. Heyndrickx, T. Ivens, K. Vereecken, R. Schoones, P. van de Wiel, and G. van der Groen. 1997. Reactivity and amplification efficiency of the NASBA HIV-1 RNA amplification system with regard to different HIV-1 subtypes. J. Virol. Methods 66:293-301.
23. Hammer, S., C. Crumpackcr, R. D'Aquila, B. Jackson, J. Lathey, D. Livnat, and P. Reichelderfer. 1993. Use of virologie assays for detection of human immunodeficiency virus in clinical trials: recommendations of the AIDS Clinical Trials Group Virology Committee. J. Clin. Microbiol. 31:2557-2564.
24. Henrard, D. R., S. Wu, J. Phillips, D. Wiesner, and J. Phair. 1995. Detection of p24 antigen with and without immune complex dissociation for longitudinal monitoring of human immunodeficiency virus type 1 infection. J. Clin. Microbiol. 33:72-75.
25. Iuliano, R., G. Forastieri, M. Brizzi, L. Mecocci, F. Mazzotta, and L. Ceccherini-Nelli. 1997. Correlation between plasma HIV-1 RNA levels and the rate of immunologic decline. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 14:408-414.
26. Kageyama, S., O. Yamada, and S. S. Muhammad. 1988. An improved method for the detection of HIV antigen in the blood of carriers. J. Virol. Methods 22:125-131.
27. Kenten, J. H., S. Gudibande, J. Link, J. J. Willey, B. Curfman, E. O. Major, and R. J. Massey. 1992. Improved clectrochemiluminescent laser for DNA probe assays: rapid quantitative assays of HIV-1 polymerase chain reaction products. Clin. Chem. 38:873-879.
28. Kestens, L., G. Hoofd, P. L. Gigase, R. Deleys, and G. Van Der Groen. 1991. HIV antigen detection in circulating immune complexes. J. Virol. Methods 31:67-76.
29. Koulinska, I., S. Stakteas, P. Vaz, and J. Barreto. 1997. Diagnosing pediatric AIDS in resource-poor settings: heat-denatured p24 antigen, anti-HIV IgA, or both? J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 16:407-408.
30. Lauré, F., V. Courgnaud, C. Rouzioux, S. Blanche, F. Veber, M. Burgard, C. Jacomet, C. Griselli, and C. Bréchot. 1988. Detection of HIV-1 DNA in infants and children by means of the polymerase chain reaction. Lancet ii: 538-541.
31. Lillo, F. B., M. Mailard, A. Saracco, and O. E. Varnier. 1997. Monitoring antiretroviral activity using ICDp24 and CD4 counts in HIV infection. J. Infect. 35:67-71.
32. MacDonell, C., J. S. Chmiel, L. Poggensee, S. Wu, and J. P. Phair. 1990. Predicting progression to AIDS: combined usefulness of CD4 - lymphocytes counts and p24 antigencmia. Am. J. Med. 89:705-712.
33. Merigan, T. C., G. Skowron, S. A. Bozzette, et al. 1989. Circulating p24 antigen levels and responses to didedoxycytidine in human immunodeficiency virus infection. Ann. Intern. Med. 110:189-194.
34. Michael, N. L., M. Vahey, D. S. Burke, and R. R. Redfield. 1992. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) type 1 infection in humans: evidence for viral replication in all stages of HIV disease. J. Virol. 66:310-316.
35. Miles, S. A., E. Balden, L. Magpantay, L. A. Wei, Leiblein, D. Hofheinz, G. Toedter, E. R. Ehm, Y. Bryson, and the Southern California Pediatric AIDS Consortium. 1993. Rapid serologic testing with immune-complex-dissociated HIV p24 antigen for early detection of HIV infection in neonates. N. Engl. J. Med. 328:297-302.
36. Moss, A. R., P. Bacchetti, D. Osmond, W. Krampf, R. E. Chaisson, D. Stites, J. Wilber, J. P. Allain, and J. P. Carison. 1988. Seropositivity for HIV-1 and the development of AIDS or AIDS related condition: three year follow-up of the San Francisco General Hospital Cohort. Br. Med. J. 296:745-750.
37. Mulder, J., N. McKinney, C. Christopherson, J. Sninsky, L. Greenfield, and S. Kwok. 1994. Rapid and simple PCR assay for quantitation of human immunodeficiency virus type 1 RNA in plasma: application to acute retroviral infection. J. Clin. Microbiol. 32:292-300.
38. Nesheim, S., F. Lee, M. L. Kalish, Ocu Cy, M. Swyer, S. Clark, L. Meadows, V. Grimes, R. J. Simonds, and A. Nahmais. 1997. Diagnosis of perinatal human immunodeficiency virus infection by polymerase chain reaction and p24 antigen detection after immune complex dissociation in an urban community hospital. J. Infect. Dis. 175:1333-1336.
39. Nishanian, P., K. R. Huskins, S. Stehn, R. Detels, and J. L. Fahey. 1990. A simple method for improved assay demonstrates that HIV p24 antigen is present as immune complexes in most sera from HIV-infected individuals. J. Infect. Dis. 162:21-28.
40. O'Shea, S., T. Rostrom, A. S. Hamblin, S. J. Palmer, and J. E. Banatvala. 1991. Quantification of HIV: correlation with clinical, virological and immunological status. J. Med. Virol. 35:65-69.
41. Phillips, S. K., B. Parekh, and R. R. George. 1993. Comparison of methods for HIV p24 antigen tests and methods for dissociation of immune complexes, abstr. 174. First National Conference on Human Retroviruses. Washington, D.C.
42. Saag, M. S. 1997. Use of virologie markers in clinical practice. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 16(Suppl.1):S3-S13.
43. Saag, M. S., E. A. Emini, O. L. Laskin, J. Douglas, W. I. Lapidus, W. A. Schleif, R. J. Whitley, C. Hildebrand, V. W. Byrnes, J. C. Kappes, K. W. Anderson, F. E. Massari, G. M. Shaw, and the L-697,661 Working Group. 1993. A short-term evaluation of L-697,661, a non-nucleoside inhibitor of HIV-1 reverse transcriplase. N. Engl. J. Med. 329:1065-1072.
44. Schockmel, G. A., S. Yerly, and L. Perrin. 1997. Detection of low HIV-RNA levels in plasma. J. Med. Virol. 51:179-183.
45. Schüpbach, J., M. Flepp, D. Pontelli, Z. Tomasik, R. Lüthy, and J. Böni. 1992. Heat-mediated immune complex dissociation and enzyme-linked immunosorbent assay signal amplification render p24 antigen detection in plasma as sensitive as HIV-1 RNA detection by polymerase chain reaction. AIDS 10:1085-1090.
46. Sninsky, J. J., and S. Kwok. 1993. The application of quantitative polymerase chain reaction to therapeutic monitoring. AIDS 7:S29-S34.
47. Spijkerman, I. J., M. Prins, J. Goudsmit, P. J. Veugelers, R. A. Coutinho, F. Miedema, and F. de Wolf. 1997. Early and late HIV-1 RNA level and its association with other markers and disease progression in long-term AIDS-free homosexual men. AIDS 11:1383-1388.
48. Van Damme, A.-M., J. C. Schmit, and S. Van Dooren. 1996. Quantification of HIV-1 RNA in plasma: comparable results with the NASBA HIV-RNA QT and the Amplicor HIV Monitor Test. J. Acquired Immune Defic. Syndr. Hum. Retrovirol. 13:127-139.
49. Van Gemen, B., T. Kievits, R. Schukkink, D. Van Strijp, L. T. Malek, R. Sooknanan, H. G. Huisman, and P. Lens. 1993. Quantification of HIV-1 RNA in plasma using NASBA during HIV-1 primary infection. J. Virol. Methods 43:177-188.
50. Vella, S. 1995. Immunological and virological markers in HIV infection. AIDS Clin. Care 7:37-40.
51. Zhang, L. Q., P. Simmonds, C. A. Ludlam, and A. J. Leigh Brown. 1991. Detection, quantification and sequencing of HIV-1 from the plasma of sero-positive individuals and from factor VIII concentrates. AIDS 5:675-681.